This location provides a provision-by-provision implementation tracking of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) (Pub. L. 108-173). We also offer a summary of the provisions from the legislation.
CMS-4068-N | 103 | Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs-August 27, 2004 | N/A |
CMS-4068-F2 | 103 | Medicare Drug Benefit Effective CY 2006 (Title I)- Clarification | 1/1/2006 |
CMS-4068-P | 103 | Medicare Drug Benefit Effective CY 2006 (Title I) | 01/01/2006 |
CMS-4068-F | 103 | Medicare Drug Benefit Effective CY 2006 (Title I) | 1/1/2006 |
CMS-4068-F2 | 104 | Medicare Drug Benefit Effective CY 2006 (Title I)- Clarification | 01/01/2006 |
CMS-4068-P | 104 | Medicare Drug Benefit Effective CY 2006 (Title I) | 01/01/2006 |
CMS-4068-F | 104 | Medicare Drug Benefit Effective CY 2006 (Title I) | 01/01/2006 |
CMS-4080-N | 104 | Recognition of NAIC Standards for Regulation of Medicare Supplemental Insurance | 9/1/2005 |
CMS-4068-N | 104 | Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs-August 27, 2004 | N/A |
CMS-4068-N | 105 | Open Public Meeting Regarding the Development of the Model Guidelines for Categories and Classes of Drugs-August 27, 2004 | N/A |